Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: paclitaxel|GENETIC: microarray analysis|PROCEDURE: biopsy|PROCEDURE: neoadjuvant therapy|DRUG: Paclitaxel
Sponsor: Georgetown University
Collaborators: National Cancer Institute (NCI)